CN111919256A - 检测染色体非整倍性的方法、装置及系统 - Google Patents
检测染色体非整倍性的方法、装置及系统 Download PDFInfo
- Publication number
- CN111919256A CN111919256A CN201880091839.7A CN201880091839A CN111919256A CN 111919256 A CN111919256 A CN 111919256A CN 201880091839 A CN201880091839 A CN 201880091839A CN 111919256 A CN111919256 A CN 111919256A
- Authority
- CN
- China
- Prior art keywords
- window
- reads
- chromosome
- sequencing
- sequencing depth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000349 chromosome Anatomy 0.000 title claims abstract description 137
- 238000000034 method Methods 0.000 title claims abstract description 61
- 208000036878 aneuploidy Diseases 0.000 title claims abstract description 31
- 231100001075 aneuploidy Toxicity 0.000 title claims abstract description 31
- 238000012163 sequencing technique Methods 0.000 claims abstract description 211
- 238000001914 filtration Methods 0.000 claims abstract description 60
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 11
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 11
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 11
- 230000000875 corresponding effect Effects 0.000 claims description 72
- 230000002759 chromosomal effect Effects 0.000 claims description 18
- 238000012360 testing method Methods 0.000 claims description 12
- 230000008774 maternal effect Effects 0.000 claims description 11
- 210000003754 fetus Anatomy 0.000 claims description 8
- 238000011002 quantification Methods 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 238000012937 correction Methods 0.000 claims description 6
- 230000002596 correlated effect Effects 0.000 claims description 4
- 238000004590 computer program Methods 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 52
- 238000001514 detection method Methods 0.000 description 37
- 239000012634 fragment Substances 0.000 description 17
- 230000002159 abnormal effect Effects 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 238000004422 calculation algorithm Methods 0.000 description 8
- 230000001605 fetal effect Effects 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 238000010606 normalization Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 230000005856 abnormality Effects 0.000 description 5
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 208000037280 Trisomy Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 201000010374 Down Syndrome Diseases 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000007481 next generation sequencing Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241001522296 Erithacus rubecula Species 0.000 description 1
- 101001063456 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 5 Proteins 0.000 description 1
- 102100031036 Leucine-rich repeat-containing G-protein coupled receptor 5 Human genes 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 241001632422 Radiola linoides Species 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 206010044688 Trisomy 21 Diseases 0.000 description 1
- WCDYMMVGBZNUGB-ORPFKJIMSA-N [(2r,3r,4s,5r,6r)-6-[[(1r,3r,4r,5r,6r)-4,5-dihydroxy-2,7-dioxabicyclo[4.2.0]octan-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3-hydroxy-2-tetradecyloctadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](COC(=O)C(CCCCCCCCCCCCCC)C(O)CCCCCCCCCCCCCCC)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H]2OC[C@H]2O1 WCDYMMVGBZNUGB-ORPFKJIMSA-N 0.000 description 1
- 231100000071 abnormal chromosome number Toxicity 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000002669 amniocentesis Methods 0.000 description 1
- 108010038083 amyloid fibril protein AS-SAM Proteins 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004252 chorionic villi Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000009609 prenatal screening Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
一种检测染色体非整倍性的方法、装置及系统。方法包括：对待测样本中的至少一部分核酸进行测序，获得包括读段的测序结果；将读段比对到参考序列，获得比对结果，比对结果包括读段定位于具体染色体的信息；对比对结果进行过滤，包括过滤掉比对结果中定位于参考序列上比对能力非为1的区域的读段，定义参考序列中定位到参考序列唯一位置的区域的比对能力为1；对于第一染色体，基于比对结果，确定定位到该第一染色体的读段的量；比较定位到该第一染色体的读段的量与阴性样本中的定位到相应第一染色体的读段的量，以判定该第一染色体的数目。
Description
PCT国内申请，说明书已公开。
Claims (34)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2018/085866 WO2019213811A1 (zh) | 2018-05-07 | 2018-05-07 | 检测染色体非整倍性的方法、装置及系统 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111919256A true CN111919256A (zh) | 2020-11-10 |
| CN111919256B CN111919256B (zh) | 2024-10-11 |
Family
ID=68467651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201880091839.7A Active CN111919256B (zh) | 2018-05-07 | 2018-05-07 | 检测染色体非整倍性的方法、装置及系统 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN111919256B (zh) |
| WO (1) | WO2019213811A1 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117106870A (zh) * | 2022-12-30 | 2023-11-24 | 深圳市真迈生物科技有限公司 | 胎儿浓度的确定方法及装置 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111724858B (zh) * | 2020-05-14 | 2024-06-07 | 东北林业大学 | 利用软件运行基因组序列比对修补gap的方法 |
| CN113593629B (zh) * | 2021-06-29 | 2024-02-13 | 广东博奥医学检验所有限公司 | 基于半导体测序的降低无创产前检测假阳性假阴性的方法 |
| CN113990393B (zh) * | 2021-12-28 | 2022-04-22 | 北京优迅医疗器械有限公司 | 基因检测用数据处理方法、装置和电子设备 |
| CN114582427B (zh) * | 2022-03-22 | 2023-04-07 | 成都基因汇科技有限公司 | 一种渐渗区段鉴定方法及计算机可读存储介质 |
| CN114792548B (zh) * | 2022-06-14 | 2022-09-09 | 北京贝瑞和康生物技术有限公司 | 校正测序数据、检测拷贝数变异的方法、设备和介质 |
| CN118351933A (zh) * | 2024-06-18 | 2024-07-16 | 安诺优达基因科技(北京)有限公司 | 对基因组组装错误进行识别的方法和纠错的方法与相关装置 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105825076A (zh) * | 2015-01-08 | 2016-08-03 | 北京圣庭生物技术有限公司 | 消除常染色体内和染色体间gc偏好的方法及检测系统 |
| EP3118323A1 (en) * | 2015-07-13 | 2017-01-18 | Cartagenia N.V. | System and methodology for the analysis of genomic data obtained from a subject |
| CN107133495A (zh) * | 2017-05-04 | 2017-09-05 | 北京医院 | 一种非整倍性生物信息的分析方法和分析系统 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105483229B (zh) * | 2015-12-21 | 2018-10-16 | 广东腾飞基因科技股份有限公司 | 一种检测胎儿染色体非整倍体的方法及系统 |
-
2018
- 2018-05-07 WO PCT/CN2018/085866 patent/WO2019213811A1/zh active Application Filing
- 2018-05-07 CN CN201880091839.7A patent/CN111919256B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105825076A (zh) * | 2015-01-08 | 2016-08-03 | 北京圣庭生物技术有限公司 | 消除常染色体内和染色体间gc偏好的方法及检测系统 |
| EP3118323A1 (en) * | 2015-07-13 | 2017-01-18 | Cartagenia N.V. | System and methodology for the analysis of genomic data obtained from a subject |
| CN107133495A (zh) * | 2017-05-04 | 2017-09-05 | 北京医院 | 一种非整倍性生物信息的分析方法和分析系统 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117106870A (zh) * | 2022-12-30 | 2023-11-24 | 深圳市真迈生物科技有限公司 | 胎儿浓度的确定方法及装置 |
| CN117106870B (zh) * | 2022-12-30 | 2024-09-13 | 深圳市真迈生物科技有限公司 | 胎儿浓度的确定方法及装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019213811A1 (zh) | 2019-11-14 |
| CN111919256B (zh) | 2024-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111919256B (zh) | 检测染色体非整倍性的方法、装置及系统 | |
| JP6971845B2 (ja) | 遺伝子の変動の非侵襲的評価のための方法および処理 | |
| AU2015267190B2 (en) | Chromosome representation determinations | |
| JP6561046B2 (ja) | 遺伝子の変動の非侵襲性評価のための方法および処理 | |
| CN108595912B (zh) | 检测染色体非整倍性的方法、装置及系统 | |
| CN107229841B (zh) | 一种基因变异评估方法及系统 | |
| WO2017205826A1 (en) | Methods for detecting genetic variations | |
| US20210104297A1 (en) | Systems and methods for determining tumor fraction in cell-free nucleic acid | |
| CN110692101A (zh) | 用于比对靶向的核酸测序数据的方法 | |
| CN107403075A (zh) | 比对方法、装置及系统 | |
| Larson et al. | A clinician’s guide to bioinformatics for next-generation sequencing | |
| US20190362807A1 (en) | Genomic variant ranking system for clinical trial matching | |
| WO2024140881A1 (zh) | 胎儿dna浓度的确定方法及装置 | |
| WO2019213810A1 (zh) | 检测染色体非整倍性的方法、装置及系统 | |
| JP7506060B2 (ja) | 検出限界ベースの品質管理メトリック | |
| WO2019132010A1 (ja) | 塩基配列における塩基種を推定する方法、装置及びプログラム | |
| CN108629152A (zh) | 检测染色体非整倍性的方法、装置及系统 | |
| US20220399079A1 (en) | Method and system for combined dna-rna sequencing analysis to enhance variant-calling performance and characterize variant expression status | |
| KR102287096B1 (ko) | 모체 시료 중 태아 분획을 결정하는 방법 | |
| JP2024534899A (ja) | 非侵襲性出生前検査のための方法及びデバイス | |
| CN114708905A (zh) | 基于ngs的染色体非整倍体检测方法、装置、介质和设备 | |
| CN118197523A (zh) | 生成基因对照表以及生成预后康复报告的方法、系统 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40033873 Country of ref document: HK |
|
| GR01 | Patent grant |